| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.6M | — | -68.7% |
| SG&A Expense | $8.2M | — | -47.2% |
| Operating Income | -$21.8M | — | +63.1% |
| Income Tax | $0 | — | — |
| Net Income | -$20.0M | — | +64.3% |
| EPS (Basic) | -$0.32 | — | +65.2% |
| EPS (Diluted) | -$0.32 | — | +65.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.2M | -51.2% | -75.9% |
| Short-term Investments | $148.7M | +2.2% | -30.4% |
| Current Assets | $174.9M | -11.0% | -43.8% |
| Total Assets | $202.6M | -10.0% | -41.2% |
| Current Liabilities | $10.4M | -36.7% | -63.3% |
| Long-term Debt | $0 |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.2M | — | +60.6% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$4.1M | — | -105.9% |
| Financing Cash Flow | $74K | — | -85.1% |
| Free Cash Flow | -$19.2M | — | +60.9% |
| -100.0% |
| Total Liabilities | $37.4M | -15.0% | -57.3% |
| Stockholders' Equity | $165.2M | -8.9% | -35.8% |